Log In
Print
BCIQ
Print
Print this Print this
 

Tetrabik (BK-4SP)

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionSubcutaneous vaccine comprises Bordetella pertussis, diphtheria toxoid, tetanus toxoid and inactivated Savin types 1, 2 and 3 of polio virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard Indication Infectious (unspecified)
Indication DetailsVaccinate against diphtheria, pertussis, tetanus and poliomyelitis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today